BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

186 related articles for article (PubMed ID: 2989702)

  • 1. Amino-acid substitutions at codon 13 of the N-ras oncogene in human acute myeloid leukaemia.
    Bos JL; Toksoz D; Marshall CJ; Verlaan-de Vries M; Veeneman GH; van der Eb AJ; van Boom JH; Janssen JW; Steenvoorden AC
    Nature; 1985 Jun 27-Jul 3; 315(6022):726-30. PubMed ID: 2989702
    [TBL] [Abstract][Full Text] [Related]  

  • 2. ras gene activation in a minor proportion of the blast population in acute myeloid leukemia.
    Toksoz D; Farr CJ; Marshall CJ
    Oncogene; 1987; 1(4):409-13. PubMed ID: 3330783
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Analysis of RAS gene mutations in acute myeloid leukemia by polymerase chain reaction and oligonucleotide probes.
    Farr CJ; Saiki RK; Erlich HA; McCormick F; Marshall CJ
    Proc Natl Acad Sci U S A; 1988 Mar; 85(5):1629-33. PubMed ID: 3278322
    [TBL] [Abstract][Full Text] [Related]  

  • 4. 12th codon mutation resulting in c-N-ras activation in acute myelogenous leukemia.
    Needleman SW; Devine SE; Kraus MH
    Leukemia; 1988 Feb; 2(2):91-3. PubMed ID: 3278172
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mutations in N-ras predominate in acute myeloid leukemia.
    Bos JL; Verlaan-de Vries M; van der Eb AJ; Janssen JW; Delwel R; Löwenberg B; Colly LP
    Blood; 1987 Apr; 69(4):1237-41. PubMed ID: 3103719
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A point mutation at codon 13 of the N-ras oncogene in myelodysplastic syndrome.
    Hirai H; Kobayashi Y; Mano H; Hagiwara K; Maru Y; Omine M; Mizoguchi H; Nishida J; Takaku F
    Nature; 1987 Jun 4-10; 327(6121):430-2. PubMed ID: 3295562
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Activation of protooncogenes in spontaneously occurring non-liver tumors from C57BL/6 x C3H F1 mice.
    Candrian U; You M; Goodrow T; Maronpot RR; Reynolds SH; Anderson MW
    Cancer Res; 1991 Feb; 51(4):1148-53. PubMed ID: 1997158
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Activation mechanism of the N-ras oncogene in human leukemias detected by synthetic oligonucleotide probes.
    Nishida J; Hirai H; Takaku F
    Biochem Biophys Res Commun; 1987 Sep; 147(2):870-5. PubMed ID: 3477229
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Biological properties of human c-Ha-ras1 genes mutated at codon 12.
    Seeburg PH; Colby WW; Capon DJ; Goeddel DV; Levinson AD
    Nature; 1984 Nov 1-7; 312(5989):71-5. PubMed ID: 6092966
    [TBL] [Abstract][Full Text] [Related]  

  • 10. High frequency of N-ras activation in acute myelogenous leukemia.
    Needleman SW; Kraus MH; Srivastava SK; Levine PH; Aaronson SA
    Blood; 1986 Mar; 67(3):753-7. PubMed ID: 3456246
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Concurrent mutations in two different ras genes in acute myelocytic leukemias.
    Janssen JW; Lyons J; Steenvoorden AC; Seliger H; Bartram CR
    Nucleic Acids Res; 1987 Jul; 15(14):5669-80. PubMed ID: 3475676
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A point mutation at codon 13 of the N-ras oncogene in a human stomach cancer.
    Nishida J; Kobayashi Y; Hirai H; Takaku F
    Biochem Biophys Res Commun; 1987 Jul; 146(1):247-52. PubMed ID: 3038106
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Three different mutations in codon 61 of the human N-ras gene detected by synthetic oligonucleotide hybridization.
    Bos JL; Verlaan-de Vries M; Jansen AM; Veeneman GH; van Boom JH; van der Eb AJ
    Nucleic Acids Res; 1984 Dec; 12(23):9155-63. PubMed ID: 6595642
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Activation of an N-ras gene in acute myeloblastic leukemia through somatic mutation in the first exon.
    Gambke C; Hall A; Moroni C
    Proc Natl Acad Sci U S A; 1985 Feb; 82(3):879-82. PubMed ID: 3856237
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Somatic N-ras oncogene activation in a patient with acute myeloblastic leukemia.
    Moroni C; Gambke C; Signer E; Jiricny J
    Haematol Blood Transfus; 1985; 29():159-62. PubMed ID: 3861476
    [No Abstract]   [Full Text] [Related]  

  • 16. Activation of K-ras by codon 13 mutations in C57BL/6 X C3H F1 mouse tumors induced by exposure to 1,3-butadiene.
    Goodrow T; Reynolds S; Maronpot R; Anderson M
    Cancer Res; 1990 Aug; 50(15):4818-23. PubMed ID: 2196119
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Activated c-N-ras in radiation-induced acute nonlymphocytic leukemia: twelfth codon aspartic acid.
    Gumerlock PH; Meyers FJ; Foster BA; Kawakami TG; deVere White RW
    Radiat Res; 1989 Feb; 117(2):198-206. PubMed ID: 2646654
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Activation of N-ras gene in bone marrow cells from a patient with acute myeloblastic leukaemia.
    Gambke C; Signer E; Moroni C
    Nature; 1984 Feb 2-8; 307(5950):476-8. PubMed ID: 6582353
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Mutagenesis of the Ha-ras oncogene in mouse skin tumors induced by polycyclic aromatic hydrocarbons.
    Bizub D; Wood AW; Skalka AM
    Proc Natl Acad Sci U S A; 1986 Aug; 83(16):6048-52. PubMed ID: 3016738
    [TBL] [Abstract][Full Text] [Related]  

  • 20. High frequency of RAS oncogene mutation in chronic myeloid leukemia patients with myeloblastoma.
    Tanaka K; Takauchi K; Takechi M; Kyo T; Dohy H; Kamada N
    Leuk Lymphoma; 1994 Apr; 13(3-4):317-22. PubMed ID: 8049652
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.